Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.11 USD | -0.39% | -1.20% | +65.54% |
May. 10 | Wedbush Raises Edgewise Therapeutics' PT to $31 From $26, Keeps Outperform Rating | MT |
May. 09 | Edgewise Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+65.54% | 1.69B | |
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B |
- Stock Market
- Equities
- EWTX Stock
- News Edgewise Therapeutics, Inc.
- JPMorgan Adjusts Price Target for Edgewise Therapeutics to $28 From $32, Maintains Overweight Rating